CreditAccess Grameen Q4 FY26 results due May 8, 2026

What the BSE filing says

CreditAccess Grameen Ltd has informed BSE that its Board of Directors will meet on May 8, 2026 to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The company indicated that earnings are expected on 08/05/2026. The board meeting notice has been issued under Regulation 29 and Regulation 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

For investors, this is the key statutory event that finalises the audited numbers for FY26 and the March quarter, and sets up the latest management commentary. The board approval is typically followed by the company’s disclosures to the exchange, including the audited financial statements and the related results documents.

Board meeting schedule and purpose

The meeting is scheduled for Friday, May 08, 2026, with the stated agenda to review and approve audited financial statements and results for Q4 FY26 and the full financial year ended March 31, 2026. The company’s intimation is framed as a compliance update to the exchange, rather than an operating update.

While the filing does not provide financial figures for Q4 FY26 or FY26, it clarifies the timing of when investors should expect the audited results to be considered. It also puts the market on notice for the company’s results-day engagement with analysts and investors.

Results conference call at 6:15 PM IST

Following the board meeting, CreditAccess Grameen will host a Q4 FY26 results conference call at 6:15 PM IST on the same day. The call is positioned as an investor and analyst interaction around quarterly and annual performance, featuring the senior management team.

The company’s communication notes that the call will be hosted by ICICI Securities. For coordination, the call coordinator is listed as Mr. Jaideep Goswami (jaideep.goswami@icicisecurities.com). The disclosure also references that international access numbers and participant support details have been provided as part of the arrangements.

Share price snapshots mentioned in the update

The information provided alongside the announcement includes multiple price snapshots and performance metrics, reflecting different time stamps in the source material. One snapshot shows CreditAccess Grameen at ₹1,497.00, up ₹6.60 (+0.44%), with 1-year returns of +31.66%.

Another data point states the stock moved up by 0.02% from a previous close of ₹1,235.60, with the last traded price cited as ₹1,235.80. Separately, a Q&A-style line states the share price was ₹1,242.60 as on 10 Apr, 2026, 09:16 AM IST, and up by 0.57% versus a previous share price of ₹1,235.4.

These figures are not presented as a single continuous tape, but they indicate that the company’s results-date announcement is being tracked alongside recent trading context.

Recent employee stock actions disclosed

The material also notes that CreditAccess Grameen Limited allotted 9,850 equity shares of face value ₹10 each under its ESOP to 12 employees on March 06, 2026. In addition, it states the Board approved 9,12,500 stock options for employees with an exercise price of ₹1,344.97.

Such disclosures are typically monitored for dilution impact and employee retention signalling, especially in financial services businesses that operate at scale across multiple regions.

Financial and regulatory metrics cited

The text includes selected operating and regulatory metrics without specifying the exact period in the excerpt. It states that total income grew 7.92% to ₹1,491.31 crore, while impairment provisions declined to ₹342.57 crore. It also cites capital and liquidity measures, including CRAR of 26.44% and LCR of 195.89%.

These metrics, when referenced around results communications, are generally used by the market to evaluate growth, provisioning intensity, and balance sheet buffers. However, the provided excerpt does not attach these numbers explicitly to Q4 FY26.

Fund-raising plans referenced: NCDs and bonds

The content also references a board-approved plan to raise up to ₹2,000 crore through non-convertible debentures (NCDs). Separately, it includes an earlier board-meeting outcome dated December 10, 2025, where the company considered and approved issuance of foreign currency bonds of various types, and issuance of non-convertible securities including debentures, up to an aggregate limit of ₹1,500 crore.

Together, these items indicate that the company has evaluated multiple funding channels across domestic and foreign markets, including private placements. The excerpt does not specify timelines, pricing, tenors, or whether any issuance has been completed under these approvals.

Corporate actions and past board calendar

The provided corporate actions section lists prior board meetings and an earlier dividend record, offering context on the company’s disclosure cycle.

Prior board outcome highlights: leadership and auditors

An outcome note dated October 28, 2025 indicates that the Board appointed Mr. Manoj Kumar as Chairman, effective immediately. It also states Ms. Jessie Paul was appointed as Chairperson of the Nomination & Remuneration Committee.

The same disclosure indicates the board reviewed and approved the unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30, 2025 (Q2 2026). Additionally, M/s. Sundaram & Srinivasan, Chartered Accountants, were appointed as joint statutory auditors, subject to shareholder approval, for a term of three years commencing from FY 2026-27, replacing M/s Varma & Varma whose tenure concludes at the end of the AGM in 2026.

What to track on May 8

The May 8 board meeting is the formal step for approving audited Q4 FY26 and FY26 results. The investor call later the same day at 6:15 PM IST provides a scheduled forum for management to discuss performance for the quarter and full year.

Given the additional disclosures referenced in the same information set - including ESOP allotments, employee stock option approvals, and fund-raising plans - investors typically watch for updated commentary on balance sheet strength and funding initiatives alongside the audited numbers.

Conclusion

CreditAccess Grameen’s BSE intimation sets May 8, 2026 as the key date for approval of audited Q4 FY26 and FY26 results, followed by a results conference call at 6:15 PM IST hosted by ICICI Securities. The next confirmed event in the company’s calendar, as disclosed, is the board meeting and the same-day investor interaction, after which the audited results are expected to be published to the exchange.